Biogen Reports Breakthrough Tau Therapy Alzheimer Data
CAMBRIDGE, Mass., May 14, 2026 Biogen Inc. has announced promising topline results from its Phase 2 CELIA study evaluating...
cognitive decline
Advertisement
Tiziana Life Sciences Nasal Therapy Boosts Brain Health
Boston, MA, USA – April 1, 2026 In a promising development for age-related cognitive decline and neurodegenerative disorders, Tiziana...
Creative Medical Technology Pioneers Regenerative Immunotherapy with AI-Enhanced Cell Platforms
Phoenix, AZ – October 27, 2025: Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company, has issued...
Sanofi Q3 2025 Results: Strong Growth and Key Approvals
PARIS – October 24, 2025 Sanofi reported a 7.0% sales increase at constant exchange rates (CER) for Q3 2025,...
Labcorp Expands Alzheimer’s Detection with FDA-Cleared Test
BURLINGTON, N.C. – October 23, 2025 Labcorp (NYSE: LH), a global leader in laboratory diagnostics, announced it will soon...
Advertisement
